BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Bispo M, Valente A, Maldonado R, Palma R, Glória H, Nóbrega J, Alexandrino P. Anabolic steroid-induced cardiomyopathy underlying acute liver failure in a young bodybuilder. World J Gastroenterol 2009; 15(23): 2920-2922 [PMID: 19533818 DOI: 10.3748/wjg.15.2920]
URL: https://www.wjgnet.com/1007-9327/full/v15/i23/2920.htm
Number Citing Articles
1
Patrick Hansma, Francisco J. Diaz, Chantel Njiwaji. Fatal Liver Cyst Rupture Due to Anabolic Steroid UseAmerican Journal of Forensic Medicine & Pathology 2016; 37(1): 21 doi: 10.1097/PAF.0000000000000218
2
Stefano Giannotti, Marco Ghilardi, Giacomo Dell’Osso, Giulia Bugelli, Giulio Guido. Left ventricular hypertrophy and spontaneous rupture of the Achilles tendon after anabolic steroids in bodybuilderEuropean Orthopaedics and Traumatology 2014; 5(4): 363 doi: 10.1007/s12570-013-0242-y
3
Medical Toxicology of Drug Abuse2012; : 275 doi: 10.1002/9781118105955.ch15
4
Jason M. Nagata, Vivienne M. Hazzard, Kyle T. Ganson, S. Bryn Austin, Dianne Neumark-Sztainer, Marla E. Eisenberg. Muscle-building behaviors from adolescence to emerging adulthood: A prospective cohort studyPreventive Medicine Reports 2022; 27: 101778 doi: 10.1016/j.pmedr.2022.101778
5
Cheng Li, Binay Kumar Adhikari, Lu Gao, Shuai Zhang, Quan Liu, Yonggang Wang, Jian Sun. Performance-Enhancing Drugs Abuse Caused Cardiomyopathy and Acute Hepatic Injury in a Young BodybuilderAmerican Journal of Men's Health 2018; 12(5): 1700 doi: 10.1177/1557988318783504
6
Kyle T. Ganson, Dylan B. Jackson, Alexander Testa, Jason M. Nagata. Performance-Enhancing Substance Use and Intimate Partner Violence: A Prospective Cohort StudyJournal of Interpersonal Violence 2022; 37(23-24): NP22944 doi: 10.1177/08862605211073097
7
Kyle T. Ganson, Dylan B. Jackson, Alexander Testa, Pamela M. Murnane, Jason M. Nagata. Performance-Enhancing Substance Use and Sexual Risk Behaviors among U.S. Men: Results from a Prospective Cohort StudyThe Journal of Sex Research 2022; 59(6): 758 doi: 10.1080/00224499.2021.2012114
8
Donald G. Barceloux, Robert B. Palmer. Anabolic—Androgenic SteroidsDisease-a-Month 2013; 59(6): 226 doi: 10.1016/j.disamonth.2013.03.010
9
Geoff Bates, Marie-Claire Van Hout, Joseph Tay Wee Teck, Jim McVeigh. Treatments for people who use anabolic androgenic steroids: a scoping reviewHarm Reduction Journal 2019; 16(1) doi: 10.1186/s12954-019-0343-1
10
Kyle T. Ganson, Deborah Mitchison, Stuart B. Murray, Jason M. Nagata. Legal Performance-Enhancing Substances and Substance Use Problems Among Young AdultsPediatrics 2020; 146(3) doi: 10.1542/peds.2020-0409
11
Shivakumar Chitturi, Geoffrey C Farrell. Drug-Induced Liver Disease2013; : 605 doi: 10.1016/B978-0-12-387817-5.00033-9
12
Reham Mohammed Shamloul, Ahmed Fathy Aborayah, Assem Hashad, Foad Abd-Allah. Anabolic steroids abuse-induced cardiomyopathy and ischaemic stroke in a young male patientBMJ Case Reports 2014; : bcr2013203033 doi: 10.1136/bcr-2013-203033
13
Onyedika J. Ilonze, Chioma O. Enyi, Chibuzo C. Ilonze. Cardiomyopathy and heart failure secondary to anabolic-androgen steroid abuseBaylor University Medical Center Proceedings 2022; 35(3): 363 doi: 10.1080/08998280.2022.2039496
14
Frederick J. Flo, Obiajulu Kanu, Mohamed Teleb, Yuefeng Chen, Tariq Siddiqui. Anabolic androgenic steroid–induced acute myocardial infarction with multiorgan failureBaylor University Medical Center Proceedings 2018; 31(3): 334 doi: 10.1080/08998280.2018.1460130
15
Kyle T. Ganson, Alexander Testa, Dylan B. Jackson, Jason M. Nagata. Performance-enhancing substance use and criminal offending: A 15-year prospective cohort studyDrug and Alcohol Dependence 2021; 226: 108832 doi: 10.1016/j.drugalcdep.2021.108832
16
Varun Takyar, Andrew Stolz. Spectrum of Drug Induced Liver Injury Caused by Anabolic Androgenic Steroids AbuseCurrent Hepatology Reports 2019; 18(4): 417 doi: 10.1007/s11901-019-00490-0
17
Arthi Thirumalai, Bradley D. Anawalt. Androgenic Steroids Use and AbuseUrologic Clinics of North America 2022; 49(4): 645 doi: 10.1016/j.ucl.2022.07.008
18
Harrison G. Pope, Ruth I. Wood, Alan Rogol, Fred Nyberg, Larry Bowers, Shalender Bhasin. Adverse Health Consequences of Performance-Enhancing Drugs: An Endocrine Society Scientific StatementEndocrine Reviews 2014; 35(3): 341 doi: 10.1210/er.2013-1058
19
Daniel Costa De Souza, José Alexandre Barbosa dos Santos, Daniery Marques De Jesus, Paulo Gentil. Biochemical Profile and Body Composition Alteration of Amateur Bodybuilders during the Pre-Contest PeriodJournal of Functional Morphology and Kinesiology 2018; 3(2): 26 doi: 10.3390/jfmk3020026
20
Han Wang, Peng Wang, Xiaoya Zhao, Cheng Ye, Xiyue Zheng, Wei Cao. Determination of anabolic androgenic steroids in dietary supplements and external drugs by magnetic solid‐phase extraction combined with high‐performance liquid chromatography–tandem mass spectrometryJournal of Separation Science 2021; 44(9): 1939 doi: 10.1002/jssc.202001062
21
Patricia Silveira de Farias, Fátima Cecchetto, Paulo Rodrigo Pedroso da Silva. Homens e mulheres com H(GH): gênero, masculinidades e anabolizantes em jornais e revistas de 2010Cadernos Pagu 2014; (42): 417 doi: 10.1590/0104-8333201400420417
22
M.N.G. Dukes. A worldwide yearly survey of new data in adverse drug reactionsSide Effects of Drugs Annual 2011; 33: 851 doi: 10.1016/B978-0-444-53741-6.00040-4
23
Eberhard Nieschlag, Elena Vorona. Doping with anabolic androgenic steroids (AAS): Adverse effects on non-reproductive organs and functionsReviews in Endocrine and Metabolic Disorders 2015; 16(3): 199 doi: 10.1007/s11154-015-9320-5
24
Fátima Cecchetto, Danielle Ribeiro de Moraes, Patrícia Silveira de Farias. Distintos enfoques sobre esteroides anabolizantes: riscos à saúde e hipermasculinidadeInterface - Comunicação, Saúde, Educação 2012; 16(41): 369 doi: 10.1590/S1414-32832012005000008
25
Antoine AbdelMassih, Mervat Haroun, Mohamed Samir, Samar Younis, Martina Tamer, Amr Salem. Hypoalbuminemia linked to myocardial dysfunction in recent-onset nephrotic syndrome: a cross-sectional case control 3DSTE studyEgyptian Pediatric Association Gazette 2021; 69(1) doi: 10.1186/s43054-021-00070-2
26
Peter Angell, Neil Chester, Danny Green, John Somauroo, Greg Whyte, Keith George. Anabolic Steroids and Cardiovascular RiskSports Medicine 2012; 42(2): 119 doi: 10.2165/11598060-000000000-00000
27
Paulo Adriano Schwingel, Helma Pinchemel Cotrim, Crimério Ribeiro dos Santos, Adriano Oliveira dos Santos, Antônio Ricardo Cardia Ferraz de Andrade, Marcos Vinicius Vilas Boas Carruego, Cláudio Cesar Zoppi. Recreational Anabolic-Androgenic Steroid Use Associated With Liver Injuries Among Brazilian Young MenSubstance Use & Misuse 2015; 50(11): 1490 doi: 10.3109/10826084.2015.1018550
28
Emiliano Medei, Moacir Marocolo, Deivid de Carvalho Rodrigues, Paulo Cesar Arantes, Christina Maeda Takiya, Juliana Silva, Edson Rondinelli, Regina Coeli dos Santos Goldenberg, Antonio Carlos Campos de Carvalho, José Hamilton Matheus Nascimento. Chronic treatment with anabolic steroids induces ventricular repolarization disturbances: Cellular, ionic and molecular mechanismJournal of Molecular and Cellular Cardiology 2010; 49(2): 165 doi: 10.1016/j.yjmcc.2010.04.014
29
Jorge Granados, Trevor L. Gillum, Kevin M. Christmas, Matthew R. Kuennen. Prohormone supplement 3β-hydroxy-5α-androst-1-en-17-one enhances resistance training gains but impairs user healthJournal of Applied Physiology 2014; 116(5): 560 doi: 10.1152/japplphysiol.00616.2013